New Technologies

Leadless Pacemaker

The Medtronic Micra™ Leadless Pacemaker is a new pacemaker that’s miniaturized, sophisticated, and self-contained. It’s the smallest pacemaker in the world. Micra is completely self-contained, implanted directly in the heart without leads.

  • 93% smaller than conventional pacemakers
  • Designed to eliminate pocket- and lead-related complications
  • FDA approved for 1.5 T or 3 T MRI scans

Make an appointment with Dr. Bagheri to discuss your treatment options with the new Medtronic Micra™ .

Request an Appointment


The CardioMEMS™ HF System is the first and only FDA-approved heart failure (HF) monitoring system proven to significantly reduce HF hospital admissions and improve quality of life.

If you have heart failure, changes in the pressure of blood through your pulmonary artery (PA) can indicate worsening heart failure—even before you notice symptoms such as shortness of breath or weight gain. The CardioMEMS™ HF System features a small pressure-sensing device that is implanted directly into your pulmonary artery. It sends information wirelessly to your doctor. Your doctor can use the information to adjust your medications and treatment plan, if needed.

Trans-Catheter Aortic Valve Replacement (TAVR)

Trans-catheter aortic valve replacement (TAVR) is a minimally invasive procedure to replace a narrowed aortic valve that fails to open properly (aortic valve stenosis). Trans-catheter aortic valve replacement is sometimes called trans-catheter aortic valve implantation (TAVI).

  • Minimally-invasive, catheter approach to heart valve replacement
  • Utilized in patients with severe aortic stenosis

Make an appointment with Dr. Bagheri to discuss your treatment options.

Request an Appointment

Advanced Procedural Techniques

We are committed to bringing you the latest in healthcare innovations and strive to stay one step ahead of the rest.

Diamond Orbital Atherectomy at AVICC

OAS is the Smart Solution for Arterial Calcium. Coronary calcium tends to be underestimated. Calcium considered mild or moderate by angiography may actually be severe if advanced imaging such as IVUS or OCT are used.44  Moderate to severe arterial calcium is present in nearly 40% of patients who undergo a Percutaneous Coronary Intervention (PCI)

Diamondback 360® Coronary OAS’s unique mechanism of action uses a patented combination of centrifugal force and differential sanding to safely and simply reduce arterial calcium, enabling successful stent delivery.

In the ORBIT II pivotal trial, the Diamondback 360® Coronary OAS demonstrated durable results with low TLR rate of 3.4% in DES subset* at one year.
*Subjects with DES only (N=389/443)

Hear from Our Patients

Request an Appointment with Dr. Michael BagheriInterventional Cardiologist Consultantin Palm Springs, CA

First Name (required)
Email Address (required)
Phone Number